Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Tsuyoshi Takeda1, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, Japan; 3Department of Orthopaedic Surgery, Keiyu Orthopaedic Hospital,...
Saved in:
Main Authors: | Iwamoto J (Author), Sato Y (Author), Uzawa M (Author), Takeda T (Author), Matsumoto H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
by: Iwamoto J, et al.
Published: (2022) -
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
by: Iwamoto J, et al.
Published: (2018) -
Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I
by: Iwamoto J, et al.
Published: (2012) -
Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2009) -
Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2010)